We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Adient (ADNT) Down 7.6% Since Last Earnings Report: Can It Rebound?
Read MoreHide Full Article
It has been about a month since the last earnings report for Adient (ADNT - Free Report) . Shares have lost about 7.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Adient due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Adient reported adjusted earnings per share (EPS) of 27 cents for the first quarter of fiscal 2025. Earnings fell from 31 cents recorded in the year-ago period but surpassed the Zacks Consensus Estimate of 24 cents.
The company generated net sales of $3.5 billion, which decreased 5% year over year but beat the Zacks Consensus Estimate of $3.43 billion.
Segmental Performance
Adient currently operates through three reportable segments — Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.61 billion, which declined 2.2% from the year-ago period and marginally missed the Zacks Consensus Estimate of $1.62 billion. The segment recorded an adjusted EBITDA of $85 million, which increased from $80 million recorded in the prior-year quarter due to favorable volume and mix as well as improved business performance in freight and launch costs. The metric, however, missed the Zacks Consensus Estimate of $86 million.
The EMEA segment registered revenues of $1.13 billion, which declined 10.9% year over year and missed the Zacks Consensus Estimate of $1.15 billion. The segment recorded an adjusted EBITDA of $22 million, which declined from $45 million generated in the year-ago period and missed the Zacks Consensus Estimate of $29.2 million due to a decline in customer production volumes.
In the fiscal first quarter, revenues in the Asia segment came in at $772 million, which rose slightly from $770 million in the fiscal first quarter of 2024 and surpassed the Zacks Consensus Estimate of $722 million. The segment recorded an adjusted EBITDA of $111 million, down from $114 million recorded in the corresponding quarter of fiscal 2024 due to unfavorable volume and mix in China. The figure, however, beat the Zacks Consensus Estimate of $108 million.
Financial Position
Adient had cash and cash equivalents of $860 million as of Dec. 31, 2024, compared with $945 million as of Sept. 30, 2024.
As of Dec. 31, 2024, long-term debt amounted to $2.4 billion.
Capital expenditures totaled $64 million compared with $55 million in the prior-year quarter.
During the quarter under review, ADNT repurchased shares worth $25 million.
Revised Guidance for FY25
Adient now envisions fiscal 2025 revenues to be $13.9 billion, down from the previous estimation of $14.1-$14.4 billion. Adjusted EBITDA is estimated to be $850 million compared with the prior expected range of $850-$900 million. Equity income is projected to be $80 million.
Free cash flow is anticipated to be $180 million, down from the previous estimate of $200 million. Capex is estimated to be $285 million. Cash tax is expected to be $105 million, while interest expenses are projected to be $185 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -14.3% due to these changes.
VGM Scores
At this time, Adient has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Adient has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Adient (ADNT) Down 7.6% Since Last Earnings Report: Can It Rebound?
It has been about a month since the last earnings report for Adient (ADNT - Free Report) . Shares have lost about 7.6% in that time frame, underperforming the S&P 500.
Will the recent negative trend continue leading up to its next earnings release, or is Adient due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important catalysts.
Adient Q1 Earnings Surpass Expectations, FY25 Sales View Cut
Adient reported adjusted earnings per share (EPS) of 27 cents for the first quarter of fiscal 2025. Earnings fell from 31 cents recorded in the year-ago period but surpassed the Zacks Consensus Estimate of 24 cents.
The company generated net sales of $3.5 billion, which decreased 5% year over year but beat the Zacks Consensus Estimate of $3.43 billion.
Segmental Performance
Adient currently operates through three reportable segments — Americas, including North America and South America; Europe, which includes the Middle East and Africa (EMEA); and Asia Pacific/China (Asia).
In the reported quarter, the Americas segment recorded revenues of $1.61 billion, which declined 2.2% from the year-ago period and marginally missed the Zacks Consensus Estimate of $1.62 billion. The segment recorded an adjusted EBITDA of $85 million, which increased from $80 million recorded in the prior-year quarter due to favorable volume and mix as well as improved business performance in freight and launch costs. The metric, however, missed the Zacks Consensus Estimate of $86 million.
The EMEA segment registered revenues of $1.13 billion, which declined 10.9% year over year and missed the Zacks Consensus Estimate of $1.15 billion. The segment recorded an adjusted EBITDA of $22 million, which declined from $45 million generated in the year-ago period and missed the Zacks Consensus Estimate of $29.2 million due to a decline in customer production volumes.
In the fiscal first quarter, revenues in the Asia segment came in at $772 million, which rose slightly from $770 million in the fiscal first quarter of 2024 and surpassed the Zacks Consensus Estimate of $722 million. The segment recorded an adjusted EBITDA of $111 million, down from $114 million recorded in the corresponding quarter of fiscal 2024 due to unfavorable volume and mix in China. The figure, however, beat the Zacks Consensus Estimate of $108 million.
Financial Position
Adient had cash and cash equivalents of $860 million as of Dec. 31, 2024, compared with $945 million as of Sept. 30, 2024.
As of Dec. 31, 2024, long-term debt amounted to $2.4 billion.
Capital expenditures totaled $64 million compared with $55 million in the prior-year quarter.
During the quarter under review, ADNT repurchased shares worth $25 million.
Revised Guidance for FY25
Adient now envisions fiscal 2025 revenues to be $13.9 billion, down from the previous estimation of $14.1-$14.4 billion. Adjusted EBITDA is estimated to be $850 million compared with the prior expected range of $850-$900 million. Equity income is projected to be $80 million.
Free cash flow is anticipated to be $180 million, down from the previous estimate of $200 million. Capex is estimated to be $285 million. Cash tax is expected to be $105 million, while interest expenses are projected to be $185 million.
How Have Estimates Been Moving Since Then?
In the past month, investors have witnessed a downward trend in estimates revision.
The consensus estimate has shifted -14.3% due to these changes.
VGM Scores
At this time, Adient has a nice Growth Score of B, though it is lagging a lot on the Momentum Score front with a D. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of A. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Estimates have been broadly trending downward for the stock, and the magnitude of these revisions indicates a downward shift. It's no surprise Adient has a Zacks Rank #4 (Sell). We expect a below average return from the stock in the next few months.